PREDICTION ANALYTICS RESEARCH SOLUTION AND EXECUTION LIMITED (EIN 474999444) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

SUCHUN CHENG

Phone

6175488520

Tax Period

2023-01-01 to 2023-12-31

PREDICTION ANALYTICS RESEARCH SOLUTION AND EXECUTION LIMITED, founded in 2015, is a small nonprofit in the Health Care sector that reported $298K in total revenue in fiscal year 2023. The organization ran a surplus of $122K, a strong 41% operating margin.

Mission

OUR MISSION IS TO DEVELOP FREELY ACCESSIBLE ANALYTICAL TOOLS AND SOFTWARE TO AID CLINICIANS AND RESEARCHERS IN ACCURATE DISEASE DIAGNOSIS, PREDICTION, AND PERSONALIZED TREATMENT STRATEGIES, IMPROVING PATIENT CARE AND REDUCING HEALTHCARE COSTS. ADDITIONALLY, WE ARE COMMITTED TO SUPPORTING EDUCATION THROUGH STEM OUTREACH PROGRAMS AND CREATING USER-FRIENDLY, OPEN-ACCESS SOFTWARE TO BRIDGE THE GAP BETWEEN RESEARCH DATA AND PRACTICAL KNOWLEDGE IN HEALTHCARE AND PUBLIC HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $297,650

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $297,650

Expense Breakdown

Grants Paid $5,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $139,732

Other Expenses $171,074

TOTAL EXPENSES $176,074

Year-over-Year Comparison

	2023	2022	Change
Revenue	$297,650	N/A	N/A
Expenses	$176,074	N/A	N/A
Net Income	$121,576	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TIANXI CAI	PRESIDENT	1.00	Officer Director	$0	$0	$0
LEE-JEN WEI	DIRECTOR	1.00	Director	$0	$0	$0
HAJIME UNO	DIRECTOR	1.00	Director	$0	$0	$0
LU TIAN	DIRECTOR	1.00	Director	$0	$0	$0
DR SUCHUN CHENG	CHIEF OPERATING OFFICER	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$297,650	$176,074	$465,404	$121,576

PREDICTION ANALYTICS RESEARCH SOLUTION AND EXECUTION LIMITED